HHS Secretary Robert F. Kennedy Jr. (center) wants the US to invest in the cell and gene therapy space, but his vision for the field may not be aligned with many biopharma industry stakeholders. (Screenshot of FDA webstream.)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
